Document is current
Any future updates will be listed below
-
Authors
Zhong, Jim https://orcid.org/0000-0001-5325-3739
Davey, Angela
Frood, Russell
McWilliam, Alan
Shortall, Jane
Reardon, Mark
Reaves, Kimberley
Swinton, Martin
Hulson, Oliver
West, Catharine
Buckley, David
Brown, Sarah
Choudhury, Ananya
Hoskin, Peter
Henry, Ann
Scarsbrook, Andrew
-
Funding
Funding for this research was provided by:
Cancer Research UK (95653117/95653118, C19942/A28832, CTRQQR-2021\100010)
National Institute of Health Research (NIHR) Manchester Biomedical Research Centre
Cancer Research UK (CRUK) Leeds Radiotherapy Research Centre (C19942/A28832)
- License Information
-
More Information
Article History
Received: 2 January 2025
Accepted: 9 June 2025
First Online: 2 July 2025
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: Informed consent was obtained from all individual participants included in the study.
: This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the United Kingdom North West Research Ethics Committee (Validation and qualification of a multiplex hypoxia biomarker for radiotherapy individualisation in prostate cancer study (IRAS 15/NW/0559)).
: Not applicable.
